IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 914
EU - Europa 712
AS - Asia 549
SA - Sud America 62
AF - Africa 34
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 866
IT - Italia 340
SG - Singapore 297
DE - Germania 94
GB - Regno Unito 82
IN - India 55
FI - Finlandia 49
BR - Brasile 47
CN - Cina 43
SE - Svezia 34
CA - Canada 33
HK - Hong Kong 27
NL - Olanda 26
JO - Giordania 21
PK - Pakistan 21
ES - Italia 16
ID - Indonesia 16
ZA - Sudafrica 13
FR - Francia 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 10
MX - Messico 9
SA - Arabia Saudita 9
BD - Bangladesh 8
LT - Lituania 8
EG - Egitto 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 5
ET - Etiopia 5
IE - Irlanda 5
IQ - Iraq 5
IR - Iran 5
LB - Libano 5
NG - Nigeria 5
TR - Turchia 5
CY - Cipro 4
MY - Malesia 4
RO - Romania 4
BG - Bulgaria 3
EC - Ecuador 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
UA - Ucraina 3
VN - Vietnam 3
AT - Austria 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JP - Giappone 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.281
Salva come PNG Salva come JPEG
Città #
Singapore 188
Chandler 161
Munich 72
Santa Clara 62
Chicago 55
Ashburn 52
London 47
Milan 38
Lawrence 34
Princeton 34
Turku 33
Catanzaro 27
Boardman 19
Ottawa 19
Los Angeles 18
Hong Kong 17
Helsinki 16
Wilmington 15
Amman 13
Carbonia 12
San Nicola Manfredi 12
Rome 11
Spezzano della Sila 10
Brooklyn 9
New York 9
San Francisco 9
Delhi 8
Irbid 8
Madrid 8
Olomouc 8
Palermo 8
Cosenza 7
Kaunas 7
Naples 7
The Dalles 7
Atlanta 6
Chennai 6
Des Moines 6
Ercolano 6
Redmond 6
Afragola 5
Aversa 5
Cardiff 5
Dallas 5
Hyderabad 5
Johannesburg 5
Lucknow 5
Meppel 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Seattle 5
Stockholm 5
São Paulo 5
Addis Ababa 4
Ahmedabad 4
Beijing 4
Brescia 4
Cape Town 4
Catania 4
Council Bluffs 4
Frankfurt am Main 4
Jeddah 4
Kuala Lumpur 4
Lahore 4
Nicosia 4
Pune 4
Toronto 4
Acquaviva delle Fonti 3
Ajman 3
Amsterdam 3
Andover 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Castrovillari 3
Charlotte 3
Chía 3
Decollatura 3
Dubai 3
Faisalabad 3
Guangzhou 3
Hanover 3
Islamabad 3
Lima 3
Melbourne 3
Mileto 3
Mountain View 3
Noida 3
Oristano 3
Oxford 3
Paola 3
Parma 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
Santo Tirso 3
Shanghai 3
Totale 1.312
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 369
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 87
miR-22 suppresses DNA ligase III addiction in multiple myeloma 85
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 83
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 70
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 62
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 59
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 56
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 55
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 53
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 49
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 49
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 45
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 44
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 43
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 42
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 41
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 41
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 40
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 40
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 38
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 37
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 37
Mmrf-commpass data integration and analysis for identifying prognostic markers 37
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 37
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 36
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 36
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 36
Integration of DNA Microarray with Clinical and Genomic Data 36
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 35
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 35
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 34
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 33
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 33
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 33
null 31
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 30
Ethical Perspectives on Pharmacogenomic Profiling 29
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 29
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 27
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 27
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 26
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 25
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 22
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 22
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 21
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 20
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 20
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 20
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 17
The potential role of miRNAs in multiple myeloma therapy 17
Advances in Alport syndrome diagnosis using next-generation sequencing 17
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 17
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 14
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 13
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 10
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 8
Totale 2.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 1 2 6 5 6 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/2026190 130 60 0 0 0 0 0 0 0 0 0 0
Totale 2.408